Evidence map›Paper›PMID 12824448›Full record

ArticleThe Journal of physiology2003

Activation and block of mouse muscle-type nicotinic receptors by tetraethylammonium.

Gustav Akk, Joe Henry Steinbach

Abstract read
In one paragraph

Article in The Journal of physiology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 31 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Isoform-specific mechanisms of α3β4*-nicotinic acetylcholine receptor modulation by the prototoxin lynx1.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2017
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Probing protein packing surrounding the residues in and flanking the nicotinic acetylcholine receptor M2M3 loop.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2009
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Galantamine activates muscle-type nicotinic acetylcholine receptors without binding to the acetylcholine-binding site.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2005
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Gustav AkkDepartment of Anesthesiology, Washington University-St Louis, Campus Box 8054, 660 S. Euclid Avenue, St Louis, MO 63110, USA. akk@morpheus.wustl.edu
Joe Henry Steinbach
Washington University in St. Louis · US

Funding

Aceytylcholine Receptor FunctionR01NS022356 · NINDS · WASHINGTON UNIVERSITY · PI STEINBACH, JOSEPH H. · 1985 to 2013
$3.8M
NINDS NIH HHS NS 22356NINDS NIH HHS R01 NS022356
6 · The paper itself

Abstract

We have studied the activation and inhibition of the mouse muscle adult-type nicotinic acetylcholine receptor by tetraethylammonium (TEA) and related quaternary ammonium derivatives. The data show that TEA is a weak agonist of the nicotinic receptor. No single-channel clusters were observed at concentrations as high as 5 mM TEA or in the presence of a mutation which selectively increases the efficacy of the receptor. When coapplied with 1 mM carbamylcholine (CCh), TEA decreased the effective opening rate demonstrating that it acts as a competitive antagonist of CCh-mediated activation. Kinetic analysis of currents elicited by CCh and TEA allowed an estimate of receptor affinity for TEA of about 1 mM, while an upper limit of 10 s-1 could be set for the wild-type channel-opening rate constant for receptors activated by TEA alone. At millimolar concentrations, TEA inhibited nicotinic receptor currents by depressing the single-channel amplitude. The effect had an IC50 of 2-3 mM, depending on the conditions of the experiment, and resembled a standard open-channel block. However, the decrease in channel amplitudes was not accompanied by an increase in the mean burst duration, indicating that a linear open-channel blocking mechanism is not applicable. Upon studying block by other nicotinic receptor ligands it was found that block by CCh, tetramethylammonium and phenyltrimethylammonium can be accounted for by the sequential blocking mechanism while block in the presence of methyltriethylammonium, ethyltrimethylammonium or choline was inconsistent with such a mechanism. A mechanism in which receptors blocked by TEA can close would account for the experimental findings.

Indexed as

AnimalsBinding SitesCarbacholCell LineCholinergic AgonistsDrug CombinationsElectric ConductivityHumansIon ChannelsMiceMusclesNicotinic AgonistsNicotinic AntagonistsQuaternary Ammonium CompoundsReceptors, NicotinicTetraethylammoniumCarbacholCholinergic AgonistsDrug CombinationsIon ChannelsNicotinic AgonistsNicotinic AntagonistsQuaternary Ammonium CompoundsReceptors, NicotinicTetraethylammonium

Identifiers

PMID12824448
PMCPMC2343137
OpenAlexW2090407735

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.